Results

Total Results: 316 records

Showing results for "vascular".

281. Archived: Evidence Summary: Atrial Fibrillation: Screening With Electrocardiography | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/atrial-fibrillation-screening-with-electrocardiography-august-2018
     August 07, 2018 - hypertension, age ≥75 years [doubled], diabetes, stroke/transient ischemic attack/thromboembolism [doubled], vascular

282. Archived: Evidence Summary: Vitamin Supplementation to Prevent Cancer and CVD: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary21/vitamin-supplementation-to-prevent-cancer-and-cvd-counseling-february-2014
     February 03, 2014 - Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial

283. Archived: Final Evidence Summary: Menopausal Hormone Therapy: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary36/menopausal-hormone-therapy-preventive-medication-2012
     May 29, 2012 - Secondary outcomes included other CHD events, vascular disease, cancer, thromboembolism, gallbladder

284. Archived: Healthy Diet Promotion: Behavioral Counseling, 1996 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/healthy-diet-promotion-behavioral-counseling-1996
     January 01, 1996 - mellitus, which accounts for over 55,000 deaths each year and is a leading cause of neuropathy, peripheral vascular

285. Screening for HIV Infection: US Preventive Services Task Force Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/efwy72cuMdhcF2jotkhTzC
     March 29, 2019 - The USPSTF reviewed several studies that reported on the long-term cardio- vascular, neuropsychiatric

286. Archived: Breast Cancer: Medications for Risk Reduction | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-medications-for-risk-reduction-2013
     September 15, 2013 - Vascular events in the Multiple Outcomes of Raloxifene Evaluation (MORE) trial: incidence, patient characteristics

287. Menopausal Hormone Therapy for the Primary Prevention of Chronic Conditions: A Systematic Review to Update the USPSTF Recommendations (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/G7CCbu64mf-nCynBkHbFLA
     July 01, 2012 - Secondary outcomes included other CHD events, vascular disease, cancer, thromboembolism, gallbladder

288. VitaminD, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: Evidence Report and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/Yc24U4wMLXGoqE5NjwRVA6
     April 17, 2018 - infarction and 1 underwent coronary artery bypass graft surgery in the vitamin D group, and no cardio- vascular

289. Evidence Summary: Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/low-dose-aspirin-use-for-the-prevention-of-morbidity-and-mortality-from-preeclampsia-preventive-medication
     September 28, 2021 - Pulmonary and systemic vascular dysfunction in young offspring of mothers with preeclampsia.

290. Screening for Atrial Fibrillation With Electrocardiography: Evidence Report and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/crPsNJ_R5SFnJhuT2CEpkr
     March 01, 2019 - tension, age �75 years [doubled], diabetes, stroke/transient ische- mic attack/thromboembolism [doubled], vascular

291. Evidence Summary: Hormone Therapy in Postmenopausal Women: Primary Prevention of Chronic Conditions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/menopausal-hormone-therapy-preventive-medication
     December 12, 2017 - Vascular effects of early versus late postmenopausal treatment with estradiol.

292. Archived: Evidence Summary: Hormone Therapy in Postmenopausal Women: Primary Prevention of Chronic Conditions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/menopausal-hormone-therapy-preventive-medication-december-2017
     December 12, 2017 - Vascular effects of early versus late postmenopausal treatment with estradiol.

293. Lipid Screening in Childhood and Adolescence for Detection of Multifactorial Dyslipidemia: Evidence Report and Systematic Review (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/9Ks34K-BnsDSBK4MYDATYS
     August 09, 2016 - Major lipids, apolipoproteins, and risk of vascular disease. JAMA. 2009;302(18):1993-2000. 43.

294. Archived: Final Evidence Review: Healthy Diet: Behavioral Counseling in Primary Care, January 2003 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review41/diet-behavioral-counseling-primary-care-adults-2003
     January 15, 2003 - Reducing blood cholesterol levels in patients with peripheral vascular disease: dietitian or diet fact

295. Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/ph_fauqHQjmrSqPAWKrARA
     September 28, 2021 - Pulmonary and systemic vascular dysfunction in young offspring of mothers with preeclampsia.

296. Archived: Postmenopausal Hormone Replacement Therapy for Primary Prevention of Chronic Conditions: Evidence Summary: Menopausal Hormone Therapy: Preventive Medication, 2002 and 2005 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/postmenopausal-hormone-replacement-therapy-for-primary-preve/v2-menopausal-hormone-therapy-preventive-medicatio
     August 21, 2002 - Risk of vascular disease in women: smoking, oral contraceptives, noncontraceptive estrogens, and other

297. Archived: Postmenopausal Hormone Replacement Therapy for Primary Prevention of Chronic Conditions: Evidence Summary: Menopausal Hormone Therapy: Preventive Medication, 2002 and 2005 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/postmenopausal-hormone-replacement-therapy-for-primary-preve/menopausal-hormone-therapy-preventive-medication-2002-2005
     August 21, 2002 - Risk of vascular disease in women: smoking, oral contraceptives, noncontraceptive estrogens, and other

298. Behavioral Counseling in Primary Care to Promote a Healthy Diet in Adults: A Summary of the Evidence (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/B-qVy6dbC25L-KAR5GvLpw
     January 01, 2010 - Reducing blood cholesterol levels in patients with peripheral vascular disease: dietitian or diet fact

299. Evidence Summary: Vitamin D Deficiency in Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/vitamin-d-deficiency-screening
     April 13, 2021 - Effect of short-term vitamin D supplementation on markers of vascular health in South Asian women living

300. Evidence Summary: Breast Cancer: Medication Use to Reduce Risk | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/breast-cancer-medications-for-risk-reduction
     September 03, 2019 - Vascular events in the Multiple Outcomes of Raloxifene Evaluation (MORE) trial: incidence, patient characteristics